期刊文献+

脑血管病预防中的抗高血压治疗策略 被引量:9

下载PDF
导出
摘要 高血压是脑血管病最常见,也是最重要的危险因素之一,降血压治疗可明显降低脑卒中的危险性。近十多年来的一些国际大型临床研究表明,在各种类型降压药中,血管紧张素Ⅱ受体阻滞剂(ARBs)在具有抗高血压作用的同时,还有不依赖降血压的心、
作者 张颖冬
出处 《临床神经病学杂志》 CAS 北大核心 2010年第5期321-325,共5页 Journal of Clinical Neurology
  • 相关文献

参考文献34

  • 1Volpe M, Tocci G. Antihypertensive therapy and cerebrovascular protection[J]. Curr Opin Nephrol Hypertens, 2006,15:498.
  • 2Redon J, Roca-Cusachs A, Mora-Macia J. Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study. Analysis of the control of blood pressure using ambulatory blood pressure monitoring[ J ]. Blood Press Monit, 2002,7 : 111.
  • 3Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication[J].Am J Hypertens, 2005,18 : 149.
  • 4Lawes CM, Bennett DA, Feigin VL,et al. Blood pressure and stroke: an overview of published reviews[ J]. Stroke,2004,35:776.
  • 5Aronow WS, Frishman WH. Treatment of hypertension and prevention of ischemic stroke [ J ]. Curr Cardiol Rep, 2004,6 : 124.
  • 6彭峰,林金秀.起始优化联合治疗:高血压治疗必然趋势[J].中华高血压杂志,2009,17(10):873-875. 被引量:6
  • 7Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events : results of prospectively-designed overviews of randomised trials[ J]. Lancet, 2003,362:1527.
  • 8Hackam DG. Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings : Yes [ J ]. Stroke, 2009,40:3159.
  • 9Schrader J, Kulschewski A, Dendorfer A. Inhibition of the RAS and stroke prevention[J]. Am J Cardiovasc Drugs, 2007,7:25.
  • 10龚培力.抗高血压药物的评价与研究进展[J].医药导报,2007,26(4):334-339. 被引量:62

二级参考文献43

  • 1张廷杰.高血压干预试验──硝苯地平与安慰剂随机对照研究[J].中华心血管病杂志,1994,22(3):201-205. 被引量:21
  • 2戴文卓,石静萍,葛剑青,方群.厄贝沙坦对急性脑梗死患者血浆溶血磷脂酸、内皮素-1和血清一氧化氮含量的影响[J].临床神经病学杂志,2007,20(2):81-83. 被引量:21
  • 3Stamler J,Neaton JD,Wentworth DN.Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease[J].Hypertension,1989,13(5 Supp):12-12.
  • 4Collins R,Peto R,MacMahon S,et al.Blood pressure,stroke,and coronary heart disease.Part 2,Short-term reductions in blood pressure:overview of randomised drug trials in their epidemiological context[J].Lancet,1990,335(8693):827-838.
  • 5Gueyffier F,Froment A,Gouton M.New meta-analysis of treatment trials of hypertension:improving the estimate of therapeutic benefit[J].J Hum Hypertens,1996,10(1):1-8.
  • 6Neal B,MacMahon S.An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals.World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration[J].Clin Exp Hypertens,1999,21(5-6):517-529.
  • 7Zanchetti A,Mancia G.Searching for information from unreported trials-amnesty for the past and prospective meta-analyses for the future[J].J Hypertens,1998,16(2):125.
  • 8PATS协作组.卒中后降压治疗研究[J].中华医学杂志,1995,108:710-717.
  • 9Wang JG,Liu G,Wang X,et al.Long-term blood pressure control in older Chinese patients with isolated systolic hypertension:a progress report on the Syst-China trial[J].J Hum Hypertens,1996,10(11):735-742.
  • 10Gong L,Zhang W,Zhu Y,et al.Shanghai trial of nifedipine in the elderly (STONE)[J].J Hypertens,1996,14 (10):1237-1245.

共引文献83

同被引文献63

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部